REMSX
Price
$16.69
Change
-$0.03 (-0.18%)
Updated
Sep 20 closing price
VEMAX
Price
$37.66
Change
-$0.15 (-0.40%)
Updated
Sep 20 closing price
Ad is loading...

REMSX vs VEMAX

Header iconREMSX vs VEMAX Comparison
Open Charts REMSX vs VEMAXBanner chart's image
Russell Inv Emerging Markets S
Price$16.69
Change-$0.03 (-0.18%)
VolumeN/A
CapitalizationN/A
Vanguard Emerging Mkts Stock Idx Adm
Price$37.66
Change-$0.15 (-0.40%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
REMSX vs VEMAX Comparison Chart
Loading...
VS
REMSX vs. VEMAX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is REMSX is a Buy and VEMAX is a Sell.

FUNDAMENTALS
Fundamentals
VEMAX has more cash in the bank: 108B vs. REMSX (772M). VEMAX pays higher dividends than REMSX: VEMAX (3.43) vs REMSX (2.33). REMSX was incepted earlier than VEMAX: REMSX (32 years) vs VEMAX (18 years). REMSX is a more actively managed with annual turnover of: 95.00 vs. VEMAX (5.00). REMSX has a lower initial minimum investment than VEMAX: REMSX (0) vs VEMAX (3000). REMSX (17.80) and VEMAX (17.78) have marching annual gain over last year. VEMAX return over 5 years is better than : 19.71 vs. REMSX (-3.76).
REMSXVEMAXREMSX / VEMAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence32 years18 years-
Gain YTD10.53010.86697%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets772M108B1%
Annual Yield % from dividends2.333.4368%
Returns for 1 year17.8017.78100%
Returns for 3 years-19.81-3.34593%
Returns for 5 years-3.7619.71-19%
Returns for 10 years-4.9824.36-20%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CANG1.610.03
+1.90%
Cango
CAPL21.270.30
+1.43%
CrossAmerica Partners LP
TXNM42.99-0.04
-0.09%
TXNM Energy Inc
CELH33.17-0.90
-2.64%
Celsius Holdings
BIVI2.74-0.09
-3.18%
BioVie Inc